The Global Deep Venous Disease Treatment Devices Market Size is valued at 1.31 billion in 2023 and is predicted to reach 2.22 billion by the year 2031 at a 6.87% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
Vein-related illnesses are conditions that damage the body's veins. One of the most prevalent disorders brought on by harmed vessel walls and valves is varicose veins. According to an article in the Journal of the American Heart Association, around 23% of adults in the United States have varicose veins. Venous reflux disease is treated using a variety of techniques, including ablation, sclerotherapy injection, ligation or stripping, and supportive care.
The market is driven by elements such as the rise in deep vein disease incidence, which increases the demand for treatment devices. The rise in deep venous disease diagnoses in hospitals, which increases the need for preventative devices, and the rise in deep venous disease awareness drives the development of deep venous disease devices in the market.
However, producers and consumers have suffered due to the pandemic. The number of treatments substantially decreased since varicose vein surgeries are not urgent. A decrease also influenced the revenue streams of the manufacturers in varicose vein surgeries or procedures due to limitations on travel. Manufacturers are taking several strategic actions to recover from COVID-19. To enhance the technology and test findings associated with the pet food flavors and ingredients market, the players are engaging in several R&D activities, product launches, and strategic collaborations.
The Deep Venous, Disease Treatment Devices market, is segmented based on products and End-user. Product segment includes Thrombectomy and Thrombolysis Devices, Inferior Vena Cava (IVC) Filters, Peripheral Vascular Stents, PTA Balloon Catheters, Accessory Devices, and Compression Devices/Stockings. By End-User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and Homecare.
During the projected period, the growing elderly population and the rising prevalence of cardiovascular disorders are anticipated to be the key drivers of the accessory device segment's growth. Cardiovascular illnesses are more prone to strike the elderly population. Over 20.8% of the European population was 65 years or older, according to Ageing Europe Statistics, 2021. Between 2021 and 2100, it is predicted that the proportion of Europeans 80 years of age or older will rise from 6.0% to 14.6%, a two-and-a-half-fold increase. Additionally, the growing desire for minimally invasive procedures will probably fuel market expansion. For instance, a minimally invasive procedure called cardiac catheterization uses thin, elastic tubes called catheters to direct them via blood vessels to the problematic areas to identify and treat several heart and vascular disorders, including May-Thurner syndrome.
Due to a growth in hospitals and surgery centers, which was the largest contributor depending on end-user in 2023, is anticipated to keep up its dominance during the projected period. However, because ambulatory surgery centers are more affordable than traditional hospitals, this market segment is predicted to develop significantly during the forecast period.
North America held a share of revenue of approximately 45.0%, dominating the market in 2023. This is mostly caused by a sizable patient population that values appearance. Due to the obvious results and safety, many are eager to undergo cosmetic operations. The proof of the safety and effectiveness of laser therapy has contributed to lowering the stigma associated with cosmetic procedures and fostering societal acceptance of laser treatments, particularly among males. The region with the quickest growth is anticipated to be Asia Pacific. Due to its huge aging population, growing disposable money, and growing knowledge of these procedures, the Asia Pacific region is anticipated to have significant growth in the years to come. Because of the various legislative considerations that affect product availability between nations, the market is extremely diversified.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 1.31 Bn |
| Revenue forecast in 2031 | USD 2.22Bn |
| Growth rate CAGR | CAGR of 6.87% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Products, End-user |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Abbott Laboratories, AndraTec GmbH, AngioDynamics, Inc., Boston Scientific Corporation, Cardinal Health, Cook Group, Innova Vascular, Inc., Koninklijke Philips N.V., Medtronic plc, Nipro Corporation, Penumbra, Inc., Stryker Corporation, Surmodics, Inc. (Vetex Medical Ltd.), Teleflex Incorporated, and Terumo Corporation. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Deep Venous Disease Treatment Devices Market By Product-
Deep Venous Disease Treatment Devices Market By End User-
Deep Venous Disease Treatment Devices Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.